Watch CBS News

FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease

The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.